H.R. 6977: To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Jan. 08, 2026 | Introduced in House |
| Jan. 08, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.